ArticleFrontiers in oncology2021

Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection.

Qingli Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.